FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Meridian Medical Technologies a Pfizer Diazepam Injection Recall

Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL aut…

Meridian Medical Technologies a Pfizer Company · Saint Louis, MO

Risk level
Class II
Reported by FDA
Jun 20, 2012
Recall ID
D-1369-2012
Check your lot numberHow we source this data

Summary

Meridian Medical Technologies a Pfizer recalled Diazepam Injection starting Jun 6, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1369-2012 on Jun 20, 2012. Reason: Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam. Status: Terminated.

Why it was recalled

Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.

Product description

Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.

Lot numbers, UPCs & expiration codes

Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13

Where it was sold

Nationwide, military, Italy, Singapore, Sweden, and Canada.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1369-2012
Classification
Class II
Status
Terminated
Recall initiated
Jun 6, 2012
FDA report date
Jun 20, 2012
Quantity
83,400 autoinjectors
Recall type
Voluntary: Firm initiated
Recalling firm
Meridian Medical Technologies a Pfizer Company

Original FDA data

Every field from FDA enforcement report D-1369-2012, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Terminated
Country
United States
Event ID
62015
Address
1945 Craig Rd
Code information
Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13
Postal code
63146-4105
Report date
Jun 20, 2012
Product type
Drugs
Recall number
D-1369-2012
Classification
Class II
Recalling firm
Meridian Medical Technologies a Pfizer Company
Product quantity
83,400 autoinjectors
Termination date
Aug 5, 2013
Reason for recall
Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.
Distribution pattern
Nationwide, military, Italy, Singapore, Sweden, and Canada.
Recall initiation date
Jun 6, 2012
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 11, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1369-2012, published Jun 20, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls